Cartesian Therapeutics files 8-K with corporate slide deck; no material news evident

Cartesian Therapeutics, Inc.

Slide deck titled 'Pioneering mRNA Cell Therapy for Autoimmunity' dated March 2025 furnished as Exhibit 99.1.
No financial results, pipeline updates, or guidance changes provided in the filing.
The exhibit is furnished under Regulation FD and contains no new material information.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.